GLP-1 Market
LLY $1251.61 ▲ +3.5% NVO $39.22 ▲ +2.9% PFE $29.44 ▲ +0.8% VKTX $27.37 ▲ +7.5% KLRA $11.71 ▲ +9.0% GPCR $22.19 ▲ +1.4% RHHBY $56.78 ▲ +2.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Gastrin 17

Company
City of Hope Medical Center
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 16, 2026

Find a Clinical Trial Near Me

See recruiting studies for Gastrin 17 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03746769

    Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes

    Not yet reported, Not yet reported City of Hope Medical Center 20 participants Est. completion 2028-08-01 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00724035

    Ultrasound-Guided Axillary or Infraclavicular Nerve Block for Upper Limb Surgery

    Not yet reported University of Parma 52 participants Est. completion 2009-07 1 site
    Other conditions: Upper Extremity, Orthopedic Surgery, Trauma, Forearm Injuries, Nerve Block
    View official trial listing →
  • Active, not recruiting NCT NCT01909245

    Islet Cell Transplant for Type 1 Diabetes

    Not yet reported City of Hope Medical Center 10 participants Est. completion 2026-09-22 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02114411

    Gastropanel for Gastric Atrophy and Cancer Risk Assessment

    Biohit Healthcare Ltd 250 participants Est. completion 2019-01-31 1 site
    Other conditions: Gastritis, Atrophic, Stomach Neoplasms
    View official trial listing →
  • Completed NCT NCT05883345

    Blood Tests for Gastritis and Gastric Neoplasms

    Konkuk University Medical Center 1490 participants Est. completion 2024-08-30 1 site
    Other conditions: Cancer Screening Tests
    View official trial listing →
  • Status unknown NCT NCT06305169

    Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer

    Sandwell & West Birmingham Hospitals NHS Trust 440 participants Est. completion 2024-07-01 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT06583057

    Multicenter Comparison of Thermal Ablation Versus Thyroid Lobectomy for Subcapsular Papillary Thyroid Microcarcinoma

    Chinese PLA General Hospital 2000 participants Est. completion 2024-07-31 1 site
    Other conditions: Thyroid Cancer, Papillary Thyroid Microcarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07060482

    Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study

    Royal College of Surgeons, Ireland 240 participants Est. completion 2026-02-01
    Other conditions: Gastric Atrophy
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.